List of companies in Mission BioCapital's investment portfolio
Name | Description | Industry | Official Website | Location | ||
|---|---|---|---|---|---|---|
Caribou Biosciences is a Berkeley, California—based private biopharmaceutical company founded in 2011 by Jennifer Doudna and Rachel Haurwitz. | ||||||
A medical company in Massachusetts focusing on lowering the cost of vaccine distribution. | ||||||
Immune system-modulating technology platform for the treatment of cancer and autoimmune diseases. | ||||||
Operator of a cellular agriculture company intended to offer clean fish and meat. The company leverages cellular agriculture technologies to address the pressing challenges of the generation like climate change, food security, and health, enabling customers to consume healthy meat alternatives. | ||||||
Dren Bio, Inc. is a protein Therapeutics founded in 2019. | ||||||
Totient is an AI Drug Discovery founded in 2017. | ||||||
Small molecule cancer drugs that stabilize the direct interaction of oncogenic proteins with the 14-3-3 class of adaptor proteins | ||||||
Shape Therapeutics is a RNA-editing gene therapy. | ||||||
March Biosciences is a clinical-stage cell therapy company that develops CAR-T cell strategies to address hematological cancers. | ||||||
Arkuda Therapeutics is a small Molecule for Dementia. | ||||||
Totient is a San Francisco-based company founded in 2017 by Kevin Britz. | ||||||
Tune Therapeutics is a company founded by Akira Matsuno. | ||||||
Nuvig Therapeutics is a biotechnology company developing therapies to induce natural mechanisms to restore immune homeostasis. | ||||||
Vedere Bio is a gene Therapy for Eyes founded in 2020. | ||||||
Alessa Therapeutics is a pre-clinical stage company that develops localized treatments for solid organ disease. |
